Medical specialists from Belgium tagged as investigators in clinical trials studying Breast Neoplasms

Total 110 results

Ahmad Awada, Dr
Seen in:
- Bruxelles, Jules Bordet
Trials:
- NCT03515798 (Principal Investigator)
Conditions:
- Inflammatory Breast Cancer
Andrea Gombos
Seen in:
- Anderlecht, Institut Jules Bordet
- Bruxelles, Institut Jules Bordet
Trials:
- NCT04675827 (Principal Investigator)
- NCT04109131 (Principal Investigator)
Conditions:
Andrée Rorive
Seen in:
- Liège, Centre Hospitalier Universitaire Sart Tilman
- Liège, Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman
Trials:
- NCT05514054 (Principal Investigator)
Conditions:
- Breast Neoplasms
Annelies Requile
Seen in:
- Hasselt, Jessa Ziekenhuis
- Limburg, Hasselt, Jessa Ziekenhuis
Trials:
- NCT05169567 (Principal Investigator)
- NCT05514054 (Principal Investigator)
- NCT06365788 (Principal Investigator)
Conditions:
Annelies Troch
Seen in:
- Lier, Heilig Hartziekenhuis
Trials:
- NCT04675827 (Principal Investigator)
Conditions:
annelore barbeaux
Seen in:
- Liège, Verviers, CHR Verviers - La Tourelle
- Verviers, CHR Verviers - La Tourelle
- Verviers, Centre Hospitalier Regional Verviers
Trials:
- NCT05512364 (Principal Investigator)
- NCT05514054 (Principal Investigator)
Conditions:
Annemie Prové
Seen in:
- Wilrijk, Antwerp, GZA Ziekenhuisen Campus Sint-Augustinus - Iridium Kankernetwerk
Trials:
- NCT04675827 (Principal Investigator)
Conditions:
Annick Delvigne, MD, PhD
Seen in:
- Liège, CHC-Saint Vincent
Trials:
- NCT04289805 (Principal Investigator)
Conditions:
- Breast Neoplasm Malignant Female
Astrid Lahousse, MSc
Seen in:
- Brussel, Jette, Vrije Universiteit Brussel (VUB)
Trials:
- NCT04531917 (Sub-Investigator)
Conditions:
Barbara Busssels
Seen in:
- Menen, AZ Delta - Campus Menen
- Roeselare, AZ Delta - Campus Rumbeke
- Torhout, AZ Delta Torhout
Trials:
- NCT05512364 (Principal Investigator)
Conditions:
Barbara Stragier
Seen in:
- Menen, AZ Delta - Campus Menen
- Roeselare, AZ Delta - Campus Rumbeke
- Torhout, AZ Delta Torhout
Trials:
- NCT05512364 (Sub-Investigator)
Conditions:
Benedicte Petit
Seen in:
- Hainaut, La Louvière, Groupe Jolimont
- Haine-Saint-Paul, Pole Hospitalier Jolimont - Hopital Jolimont
Trials:
- NCT05512364 (Principal Investigator)
- NCT05514054 (Principal Investigator)
Conditions:
Boudewijn Dullens
Seen in:
- Brasschaat, AZ KLINA Brasschaat
Trials:
- NCT05512364 (Sub-Investigator)
Conditions:
Canon
Seen in:
- Charleroi, Grand Hopital de Charleroi
Trials:
- NCT03515798 (Principal Investigator)
Conditions:
- Inflammatory Breast Cancer
Caroline Sweldens, Doctor
Seen in:
- Leuven, UZ Leuven Radiotherapy Department
Trials:
- NCT01284153 (Sub-Investigator)
Conditions:
- Breast Neoplasms;
- Radiation
Caterina Confente
Seen in:
- Haine-Saint-Paul, Pole Hospitalier Jolimont - Hopital Jolimont
Trials:
- NCT05512364 (Sub-Investigator)
Conditions:
Cedric Van Marcke De Lummen
Seen in:
- Brussels, Cliniques Universitaires Saint-Luc
Trials:
- NCT05512364 (Principal Investigator)
Conditions:
Céline Closset
Seen in:
- Bruxelles-Capitale, Région De, Auderghem, CHIREC - site delta
Trials:
- NCT05514054 (Principal Investigator)
Conditions:
- Breast Neoplasms
César Fernández-de-las-Peñas, PhD
Seen in:
- Brussel, Jette, Vrije Universiteit Brussel (VUB)
Trials:
- NCT04531917 (Sub-Investigator)
Conditions:
Chantal Van Ongeval, MD,Phd
Seen in:
- Leuven, UZLeuven
Trials:
- NCT02209129 (Principal Investigator)
- NCT01600144 (Principal Investigator)
Conditions:
- Breast Cancer;
- Data Collection
Charlotte GREGOIRE, PhD
Seen in:
- Liège, University of Liege
Trials:
- NCT05867966 (Principal Investigator)
Conditions:
Christel Fontaine
Seen in:
- Brussel, University Hospital Brussels
- Brussels, UZ Brussel
- Bruxelles-Capitale, Région De, Brussels, UZ Brussel
- Other, Bruxelles-Capitale, Universitair Ziekenhuis Brussel
Trials:
- NCT04975308 (Principal Investigator)
- NCT05132582 (Principal Investigator)
- NCT04551495 (Principal Investigator)
- NCT06365788 (Principal Investigator)
Conditions:
Christine Desmedt, PhD
Seen in:
- Leuven, UZ Leuven
Trials:
- NCT04200768 (Sub-Investigator)
Conditions:
- Breast Neoplasms
Corina De Lourdes Martinez-Mena
Seen in:
- Bruxelles-Capitale, Région De, Brussels, CHU Saint-Pierre
Trials:
- NCT05514054 (Principal Investigator)
Conditions:
- Breast Neoplasms
Corina Martinez-Mena
Seen in:
- Bruxelles-Capitale, Brussels, CHU Saint-Pierre
- Bruxelles-Capitale, Région De, Brussels, CHU Saint-Pierre
Trials:
- NCT05514054 (Principal Investigator)
Conditions:
- Breast Neoplasms
David Beckwée, PhD
Seen in:
- Brussel, Jette, Vrije Universiteit Brussel (VUB)
Trials:
- NCT04531917 (Sub-Investigator)
Conditions:
Debbie Debaere
Seen in:
- Ieper, Jan Yperman ziekenhuis
- West-Vlaanderen, Ieper, Jan Yperman ziekenhuis
Trials:
- NCT05514054 (Principal Investigator)
Conditions:
- Breast Neoplasms
Delphine Levacq
Seen in:
- Hainaut, Lodelinsart, CHU de Charleroi - Hopital Civil Marie Curie
Trials:
- NCT05514054 (Principal Investigator)
Conditions:
- Breast Neoplasms

Clinical Trials on Breast Neoplasms

Emory University
Eisai Inc.

Terminated

Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer

Breast Cancer | Breast Neoplasms | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Tumors, Breast

United States
Innocrin Pharmaceutical

Completed

CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) (CLARITY-01)

Breast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the Breast

United States
G1 Therapeutics, Inc.

Terminated

Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)

Breast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast Neoplasms

United States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia
Seagen Inc.

Completed

A Safety Study of SGN-LIV1A in Breast Cancer Patients

Triple Negative Breast Neoplasms | Hormone Receptor Positive Breast Neoplasms | HER2 Positive Breast Neoplasms | HER2 Mutations Breast Neoplasms

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
Celgene Corporation

Terminated

Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer

Inflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast Cancer

United States
University of Washington
National Cancer Institute (NCI)

Completed

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

Inflammatory Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States
Providence Health & Services
Brooklyn ImmunoTherapeutics, LLC

Active, not recruiting

Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

Breast Neoplasm | Triple Negative Breast Cancer | Breast Neoplasm, Male

United States
Joseph Baar, MD, PhD

Completed

MUC1 Vaccine for Triple-negative Breast Cancer

Breast Cancer | Stage I Breast Cancer | Inflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer

United States
Dana-Farber Cancer Institute
Conquer Cancer Foundation

Recruiting

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Inflammatory Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast

United States
Wake Forest University Health Sciences
Merck Sharp & Dohme LLC

Completed

Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer (PePPy)

Male Breast Cancer | Breast - Female

United States

Medical specialists from Belgium tagged as investigators in clinical trials studying Breast Neoplasms

Clinical Trials on Breast Neoplasms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations